SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines

<p dir="ltr">Neutralizing antibodies (NAbs) are elicited after infection and vaccination and have been well studied. However, their antibody‐dependent cellular cytotoxicity (ADCC) functionality is still poorly characterized. Here, we investigated ADCC activity in convalescent sera fr...

Full description

Saved in:

Bibliographic Details
Main Author:	Hadeel T. Zedan (12535521) (author)
Other Authors:	Maria K. Smatti (4675852) (author), Duaa W. Al‐Sadeq (22045124) (author), Hebah A. Al Khatib (10494573) (author), Eleonora Nicolai (496034) (author), Massimo Pieri (5023022) (author), Sergio Bernardini (504056) (author), Ali Ait Hssain (11264358) (author), Sara Taleb (11264352) (author), Hamda Qotba (12794976) (author), Khodr Issa (18174916) (author), Laith J. Abu Raddad (16931811) (author), Asmaa A. Althani (4675855) (author), Gheyath K. Nasrallah (9200525) (author), Hadi M. Yassine (4675846) (author)
Published:	2024
Subjects:	Biomedical and clinical sciences Clinical sciences Immunology Health sciences Public health ADCC COVID‐19 COVID‐19 vaccines humoral responses neutralizing antibodies NK cells SARS‐CoV‐2
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines

Similar Items